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Abstract
Cultured bovine aortic endothelial (BAE) cells expressed a Na/Cl3-dependent taurine uptake activity that saturated with
an apparent K0:5 ofV4.9 WM for taurine and was inhibited by L-alanine, guanidinoethane sulfonate, and homotaurine. We
isolated a taurine transporter clone from a BAE cell cDNA library that revealed s 91% sequence identity at the amino acid
level to the previously cloned high-affinity mammalian taurine transporters. The biochemical and pharmacological
properties of the bovine taurine transporter cDNA expressed in Xenopus oocyte was similar to those of the high-affinity
taurine transporter. Surprisingly, F3 blocked taurine uptake in BAE cells with an IC50 of V17.5 mM. The endogenous
taurine uptake was also inhibited by the protein kinase C activator phorbol 12-myristate 13-acetate, but not by its inactive
analog, 4K-phorbol 12,13-didecanoate. The endogenous uptake was stimulated, however, by hypertonic stress and the
increase was due to an increase in the Vmax of taurine uptake. Our results provide the first description of a molecular
mechanism that may be responsible for maintaining the intracellular taurine content in the endothelial cells. ß 2000
Elsevier Science B.V. All rights reserved.
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1. Introduction
Taurine, a sulfur containing L-amino acid, is one
of the most abundantly found free amino acids in the
central nervous system and muscles (for a review, see
[1]). The de novo synthesis of taurine occurs primar-
ily in the liver, from where the circulating blood de-
livers it to the target tissues. Most cells acquire tau-
rine from the circulating plasma. A high-a⁄nity
taurine transporter catalyzes the transport of taurine
from the circulating blood into the cells. Moreover,
the taurine transporter helps in maintaining the in-
tracellular taurine concentration. While a large body
of evidence suggests that taurine functions as an os-
molyte in a variety of tissues, taurine is also known
to attenuate the deleterious e¡ects of radiation and
oxidative damage in a number of tissues/cells [1].
The endothelial cell layer lines the blood vessels
forming a blood^solute barrier. These cells are con-
stantly exposed to the shear and stress of blood £ow
and to the changes in blood osmolarity. Little is
known about the mechanism(s) by which the endo-
thelial cells protect themselves from the long term
deleterious e¡ects of shear, stress, and osmotic
changes.
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Although taurine transport has been demonstrated
in capillary preparations from rat brains [2], in pri-
mary cultures of bovine brain capillary endothelial
cells [3,4], and in intact brains [5], the nature and
the properties of the taurine transport system in the
endothelial cells in general remain mostly unknown.
Because of taurine’s ability in preventing cell damage
and its role in regulating cell volume, it is of great
importance to know whether the endothelial cells
possess a mechanism that will concentrate taurine
in the cells. Thus, the purpose of this study is to
examine whether the endothelial cells endogenously
express a taurine transport system and to determine
its molecular properties. Our results demonstrate for
the ¢rst time that a high-a⁄nity, Na- and Cl3-de-
pendent, and hypertonic stress-sensitive taurine
transporter is expressed in cultured bovine aortic en-
dothelial cells.
2. Materials and methods
2.1. Materials
All chemicals used were ultra-pure or ACS pure
grade and were purchased from one of the general
chemical suppliers such as Sigma Chemical Co. (St.
Louis, MO), Fisher Scienti¢c Co. (Pittsburgh, PA),
Life Technologies (Gaithersburg, MD), and United
States Biochemical (Cleveland, OH).
2.2. Cell culture
Bovine aortic endothelial (BAE) cells were gener-
ous gift from Dr Diana L. Kunze (Rammelkamp
Center for Education and Research, MetroHealth
Systems, Cleveland, OH). These cells were main-
tained in DMEM supplemented with 10% FBS and
1% penicillin/streptomycin at 37‡C under 95% O2/5%
CO2. Passages between 8 and 21 were used for the
studies described here.
2.3. RNA isolation and reverse transcriptase^
polymerase chain reaction (RT^PCR) analysis
Total poly(A) RNA or total RNA was prepared
from several batches of BAE cells. Total RNA was
puri¢ed using the RNA puri¢cation kit from BioTex
(Houston, TX) or Ambion (Austin, TX). Total poly-
(A) RNA was puri¢ed from the total RNA using
oligo(dT) spin columns (Invitrogen, Carlsbad, CA).
For RT^PCR, typically V1 Wg of total poly(A)
RNA or V10 Wg of total RNA was reversed tran-
scribed into oligo(dT)/random primer-primed ¢rst
strand cDNA using the PCR Cycling kit (Invitro-
gen). An aliquot of the ¢rst-strand cDNA was used
for PCR ampli¢cation utilizing Taq DNA polymer-
ase (Perkin^Elmer, Foster City, CA) and using var-
ious combinations of forward and reverse PCR prim-
ers. These PCR primers were synthesized previously
using sequences based on the cDNA sequence of the
mTauT mouse retinal taurine transporter [6]. DNA
ampli¢cation reactions were carried out using the
following PCR cycling conditions: denature at
94‡C for 1 min, anneal at 50‡C for 1 min, and extend
at 72‡C for 2 min. At the end of 40 cycles, the re-
action mixture was incubated for 10 min at 72‡C.
DNA fragments of expected sizes were puri¢ed by
agarose gel electrophoresis and were cloned subse-
quently into the pCR2-TA cloning vector (Invitro-
gen). Plasmid DNA was prepared from at least ¢ve
independent clones containing DNA inserts and each
clone was sequenced using the Sequenase Version 2.0
DNA Sequencing kit (United States Biochemicals,
OH).
2.4. Rapid ampli¢cation of 5P-end
The 5P-end of the taurine transporter cDNA was
isolated from BAE cell total poly(A) RNA (10 Wg)
using a 5P-RACE Ampli¢cation kit (Life Technolo-
gies) following the manufacturer’s protocol and the
insert speci¢c reverse primer: 5P-CCAAGAAAAA-
CACAGGCAG-3P. The ampli¢ed DNA was gel pu-
ri¢ed and cloned into the pCR2.1-TA cloning vector
(Invitrogen). Several insert-containing clones were se-
quenced using Sequenase Version 2.0 DNA sequenc-
ing kit.
2.5. Assembly of full-length cDNA for functional
expression in oocytes
To functionally express the bTauT cDNA in Xen-
opus oocytes, we ¢rst created an expression vector
pBVLg by introducing a HindIII and SmaI digested
DNA fragment of the plasmid pCrT.3 [7] to the Hin-
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dIII and EcoRV digested pBV vector [8]. The Hin-
dIII and SmaI digested DNA fragment contained the
5P-untranslated region of the L-globin gene fused at a
NcoI site upstream to a small portion of the CRT-1
cDNA coding region. The full-length coding region
of the bTauT cDNA was assembled subsequently
from two PCR-ampli¢ed overlapping DNA frag-
ments and cloned into the pBVLg vector to create
the bTauT expression plasmid (pBVLg.bTauT) as
follows.
A cDNA fragment encoding the N-terminal 400
amino acids of the bTauT was ampli¢ed using the
following primers: forward primer, 5P-GCCATGGC-
CACGAAGGAGAAGCTGCA-3P (contains a NcoI
restriction site, which is in italics; the ¢rst codon,
within the NcoI site, is underlined), and reverse prim-
er, 5P-CAGTCCAAGCAAGAGGAGCA-3P. Simi-
larly, a cDNA fragment encoding a C-terminal por-
tion of the bTauT (corresponding to amino acids
330^621) was ampli¢ed using the following two
PCR primers: forward primer, 5P-ATGCCTGAA-
CAGTGGTACCAG-3P, and reverse primer, 5P-
TCACATCATGGTCTCCACAATGA-3P. The am-
pli¢ed fragments were cloned into the pCR2-TA vec-
tor (Invitrogen). A recombinant plasmid containing
the N-terminal coding cDNA fragment was digested
with the restriction enzymes NcoI and SacI. Simi-
larly, a recombinant plasmid containing the C-termi-
nal coding cDNA fragment was digested with the
restriction enzymes SacI and EcoRI. The appropriate
DNA fragments were puri¢ed by agarose gel electro-
phoresis and cloned subsequently into the NcoI and
EcoRI digested pBVLg expression vector. The resul-
tant recombinant plasmid, which contained the entire
coding region of the BAE cell taurine transporter,
was termed pBVLg.bTauT.
2.6. Expression in Xenopus oocytes
Oocytes were isolated from Xenopus laevis and
were used for microinjection as described [6,9]. Oo-
cytes were microinjected individually with synthetic
RNA (cRNA; V5^10 ng/oocyte) prepared from the
pBVLg.bTauT recombinant plasmid. Seventy-two
hours after injection, taurine uptake assays were per-
formed to measure the functional expression of
bTauT in the microinjected oocytes.
2.7. Taurine uptake in BAE cells
The BAE cells were seeded at a density of
V1.9U105 cells/well in 6-well culture dishes and
were incubated in the 37‡C incubator for 2^3 days
before they were used for uptake studies. Unless oth-
erwise stated, taurine uptake experiments in cells
were performed in sodium chloride bu¡er (NaCl-1
bu¡er, mM: 135 NaCl, 1 CaCl2, 2 KCl, 5 MgCl2,
5 Hepes; pH to 7.5 with Tris base). Sodium-free
bu¡ers were prepared by substituting the NaCl in
the NaCl-1 bu¡er with equimolar amount of lithium
chloride, potassium chloride, or choline chloride.
Uptake bu¡ers containing various concentrations of
Na were prepared by substituting NaCl with LiCl
or choline chloride and keeping the other ingredient
concentrations the same. Uptake bu¡ers containing
various concentrations of Cl3 were prepared by re-
placing only a given portion of the NaCl with an
equimolar amount of sodium acetate or sodium £u-
oride, while acetate salts were used for the rest of the
ingredients. In all cases, the total osmolarity of the
cell uptake bu¡er was V305 mosmol.
For uptake studies, cells were ¢rst washed with
choline chloride bu¡er, and taurine uptake was ini-
tiated by adding 1 ml of a given uptake bu¡er con-
taining [3H]taurine. After incubation at 37‡C for a
given period of time, the uptake was terminated by
aspiration, and the cells were quickly washed three
times (1 ml each time) with ice-cold choline chloride
bu¡er. Subsequently, the cells were solubilized in 1 ml
of 1% SDS by shaking for 5^10 min and then re-
peatedly passed through a pipette-tip to reduce the
viscosity of the cell extract by shearing the chro-
mosomal DNA. A fraction (900 Wl) of the solubilized
cell extract from each well was transferred to a scin-
tillation vial, mixed with 10 ml of Ultima Gold LSC-
cocktail (Packard Instruments, Meriden, CT), and
the amount of radioactivity in each fraction was
measured using a Beckman LS 3800 liquid scintilla-
tion counter. Protein content in each extract was
measured using the Pierce Protein Assay kit (Pierce,
Rockford, IL).
To determine the e¡ects of hypertonicity on tau-
rine uptake, BAE cells were seeded in 6-well culture
dishes as described above. Two to three days later,
the growth medium was replaced with a hypertonic
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(hyperosmotic) medium consisting of normal growth
medium supplemented with either 100 mM NaCl or
200 mM ra⁄nose to raise the osmolarity. Control
cells were maintained in normal growth medium
(iso-osmotic) in parallel cultures. Uptake studies
were performed as described above 24 h after the
growth medium was replaced.
2.8. Taurine uptake in oocytes
Taurine uptake experiments in oocytes were per-
formed in the oocyte sodium chloride bu¡er (NaCl-2
bu¡er, mM: 100 NaCl, 1 CaCl2, 2 KCl, 5 MgCl2,
5 Hepes; pH to 7.5 with Tris base). Compositions of
sodium-free (choline chloride, potassium chloride,
and lithium chloride) and chloride-free (sodium ace-
tate and sodium gluconate) uptake bu¡ers, and up-
take bu¡ers with various concentrations of Na and
Cl3 were previously described [6,7]. Taurine uptake
assays using microinjected oocytes and uninjected
oocytes (control) were performed as described earlier
[6].
2.9. Additional uptake experiments
Taurine uptake was measured (30 min uptake,
37‡C) as a function of various external concentra-
tions of taurine (1^60 WM), Na (0^135 mM for cells
and 0^100 mM for oocytes), and Cl3 (0^135 mM for
cells and 0^100 mM for oocytes) as described [6] to
determine their e¡ects on the rate of uptake. Results
were analyzed as described [6,7] by non-linear curve-
¢tting of the experimental data points to the modi-
¢ed Michaelis^Menten equation: V = Vmax [S]n/
{(K0:5)n+[S]n, where K0:5 is the equilibrium constant
and n is the Hill coe⁄cient.
Taurine uptake was measured in the presence of
various concentrations of known taurine transport
inhibitors, L-alanine, guanidinoethane sulfonate
(GES), and homotaurine [6]. The IC50 value for
each inhibitor was determined subsequently from
its dose^response plot [6,7]. To determine the e¡ect
of A23187 on taurine uptake, 5 WM of A23187 was
added directly to the uptake bu¡er. To determine the
e¡ects of phorbol esters on taurine uptake, cells were
pre-treated with either 100 nM of phorbol 12-myris-
tate 13-acetate (PMA), 100 nM of 4K-phorbol 12,13-
didecanoate (4K-PDD) or vehicle solvent (DMSO)
for 1 h at 37‡C. Subsequently, treated cells were
used for a 60-min uptake assay.
3. Results
3.1. Taurine uptake in bovine aortic endothelial cells
Fig. 1 shows taurine uptake by cultured monolayer
BAE cells. As shown, removal of either the external
Na (with choline, K, or Li) or the Cl3 (with
gluconate) signi¢cantly inhibited the taurine uptake,
suggesting that the endogenous taurine uptake sys-
tem in BAE cells is dependent on both Na and Cl3.
The taurine uptake increased linearly with time until
saturation and was linear almost up to 110 min (re-
sults not shown). A number of drugs known to in-
hibit taurine transport in other cells [6], also inhib-
ited the endogenously expressed taurine uptake
activity in the BAE cells in a dose dependent manner.
Table 1 lists the IC50 values of these inhibitors. For
comparison, the respective IC50 values of these drugs
for the mouse taurine transporter (mTauT) [6] are
also included.
Fig. 1. Taurine uptake in cultured BAE cells is dependent on
both Na and Cl3. Taurine uptake was initiated by adding
2 WM of [3H]taurine (100 mCi/mmol) to the cells in a given
bu¡er, and the uptake was measured as described in Section 2.
Results (average of duplicate measurements) are expressed as
percentage of uptake in NaCl-1 bu¡er (control uptake). Control
taurine uptake (100%) represents 19.45 pmol of taurine/mg pro-
tein per 30 min.
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Fig. 2. Sequence alignment of the taurine transporters. Amino acid sequences of the taurine transporters encoded by the mouse retina
(mTauT; [6]), rat brain (rTauT; [11]), human placenta (hTauT; [10]), MDCK cells (dTauT; [12]), and BAE cells (bTauT; this work;
GenBank accession no. AF260239) cDNA clones were aligned using the CLUSTALW 1.8 program, and the aligned sequences were
shaded using the BOXSHADE 3.21 program (accessed via the BCM Search Launcher, Baylor College of Medicine, Houston, TX).
Identical residues are shown as white letters in black background.
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3.2. Identi¢cation and isolation of the taurine
transporter cDNA from the BAE cells
To identify the taurine transporter expressed in
BAE cells, we initially used a RT^PCR based ap-
proach. Total RNA from the BAE cells were ana-
lyzed by RT^PCR using several mTauT-speci¢c oli-
gonucleotide primers. Initial results indicated that
BAE cells expressed a taurine transporter cDNA
which shared a high degree of sequence homology
with that of the mTauT cDNA (results not shown).
Subsequently, the entire sequence of the cDNA was
assembled from three overlapping PCR-ampli¢ed
fragments. We also used 5P-RACE method to ampli-
fy independently the 5P-end of the cDNA. Out of ten
independent recombinant plasmids bearing the am-
pli¢ed insert, only three clones revealed DNA se-
quences comprising the anticipated 5P-end of the
taurine transporter coding region and part of the
5P-untranslated region; the rest of the clones con-
tained unrelated DNA sequences (results not shown).
Sequencing of each taurine transporter 5P-RACE
clone revealed di¡erences in length of the 5P-untrans-
lated region and also veri¢ed the sequence integrity
of the N-terminal coding region. A cDNA clone con-
taining the entire coding region of the bovine taurine
transporter (bTauT) was assembled from two over-
lapping PCR ampli¢ed fragments as described in
Section 2.
Fig. 2 depicts the amino acid sequence alignment
of the bTauT taurine transporter with those of the
human placental [10], mouse retinal [6], rat brain
[11], and canine kidney derived MDCK cell [12] tau-
rine transporters. As shown, the bTauT shared
V92.9% sequence identity at the amino acid level
to the human, mouse, and rat taurine transporters,
and V96.8% sequence identity to the MDCK cell
taurine transporter.
Fig. 3 shows the induced taurine uptake in Xeno-
pus oocytes expressing the bTauT cRNA. The in-
duced taurine uptake activity in each oocyte was ro-
bust (97.0 pmol/oocyte per h) and was signi¢cantly
higher than that in the uninjected oocyte (0.6 pmol/
oocyte per h). Furthermore, the uptake was depen-
dent on both external Na and Cl3. Thus, the oo-
cytes were able to sustain taurine uptake in NaCl
bu¡er; however, the uptake was signi¢cantly inhib-
ited in choline chloride, potassium chloride, and so-
dium acetate bu¡ers.
3.3. E¡ects of external taurine, Na+, and Cl3 on
taurine uptake
The rate of taurine uptake both in cultured BAE
cells (endogenous) as well as in oocytes (expressing
the recombinant bTauT) increased when the external
concentration of taurine, Na or the Cl3 was in-
creased independently (results not shown). The rate
of uptake increased hyperbolically with the increase
in the external taurine concentration (1^60 WM). The
Fig. 3. Taurine uptake in Xenopus oocytes expressing the
bTauT taurine transporter cDNA clone. Taurine uptake in oo-
cytes individually microinjected with the bTauT cRNA was
measured for 1 h using 5 WM [3H]taurine as described in Sec-
tion 2. Results are expressed as average mean uptake (n = 8 oo-
cytes; þ S.E.). Control taurine uptake (100%) in oocytes using
NaCl bu¡er was 97.0 pmol/oocyte per h. Uninjected oocytes
were used as a negative control.
Table 1






Taurine uptake (60 min uptake at 37‡C using 5.0 WM of
[3H]taurine) was measured as a function of various concentra-
tions of a given inhibitor. IC50 for each inhibitor was deter-
mined from the respective dose^response plot.
aResults for the mTauT are taken from Vinnakota et al. [6] for
comparison.
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rate of uptake also increased hyperbolically as the
external Cl3 concentration was increased (0^135
mM for cells and 0^100 mM for oocytes) using ace-
tate as the replacement anion for Cl3. In contrast,
the rate of uptake increased sigmoidally as the exter-
nal Na concentration was increased (0^135 mM for
cells and 0^100 mM for oocytes). Similar results were
obtained irrespective of whether the Na concentra-
tion was varied by replacing Na with either choline
or Li (results not shown).
The experimental results of taurine uptake as a
function of various external concentrations of taur-
ine, Na, and Cl3 were subjected to non-linear
curve-¢t analyses as described [6] to determine the
apparent kinetic parameters (i.e., equilibrium con-
stant, Vmax, Hill coe⁄cient), which are listed in Table
2. The taurine uptake in BAE cells followed Michae-
lis^Menten kinetics that saturated with a K0:5 of 4.9
WM for taurine. Similar results were obtained with
oocytes expressing the bTauT cDNA. Based on the
Hill coe⁄cients summarized in Table 2, the bovine
taurine transporter requires at least two Na and one
Cl3 to transport one taurine across the cell mem-
brane, as has been found with the mouse, human,
and rat high-a⁄nity taurine transporters [6,10,11].
In contrast to the studies described above, in
which the external Cl3 concentration in the uptake
bu¡er was varied using acetate as the replacement
ion, a markedly di¡erent result was obtained when
these studies were performed using bu¡ers in which
the Cl3 was replaced by F3. As shown in Fig. 4,
when Cl3 was replaced by acetate, the taurine uptake
gradually decreased from 100% to about 10% of its
original value as the acetate concentration was in-
creased from 0 to 135 mM (i.e., the Cl3 concentra-
tion decreased from 135 to 0 mM). In contrast, when
Cl3 was replaced by F3, the uptake sharply de-
creased as the F3 concentration was increased from
0 to 30 mM. When the F3 concentration in the up-
take bu¡er was 40 mM, there was virtually no resid-
ual taurine uptake even though the uptake bu¡er
contained 95 mM of Cl3. The estimated IC50 for
F3 from this plot was V17.5 mM. Similar results
were also observed in oocytes expressing the bTauT
Fig. 4. E¡ect of replacing Cl3 with F3 on taurine uptake in
BAE cells. Taurine uptake was measured using 5.0 WM of
[3H]taurine (60 min uptake, 37‡C) in bu¡ers containing various
concentrations of Cl3. The Cl3 concentration in the bu¡er was
varied by replacing a given amount of NaCl in the NaCl-1
bu¡er with an equimolar amount of either NaF (b) or sodium
acetate (R) to keep the combined anion concentration at 135
mM. Results (average of duplicate measurements þ deviation)
are expressed as percentage of uptake in NaCl-1 bu¡er (control
uptake) as a function of anion (acetate or F3) concentration.
Table 2
Kinetic parameters of taurine transport
Substrate Equilibrium constant (K0:5) Vmax Hill coe⁄cient (n)
BAE bTauT BAEa bTauTb BAE bTauT
Taurine 4.9 WM 1.0 WM 17.0 77.9 1 1
Na 19.3 mM 41.9 mM 16.2 84.4 2.2 1.87
Cl3 7.5 mM 28.3 mM 14.1 97.5 1 1
The external concentration of taurine, Na, or Cl3 was varied independently and the taurine uptake was measured at each experimen-
tal condition as described in Section 2. Equilibrium constant, Vmax, and Hill coe⁄cient values were determined by non-linear curve-¢t
analyses of experimental data points as described [6] using the Sigma Plot 4.0 program (Jandel Scienti¢c, CA).
aVmax is expressed as pmol/mg protein per 30 min.
bVmax is expressed as pmol/oocyte per h.
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(results not shown). A reasonable explanation of
these results is that F3 is inhibiting the taurine up-
take by interfering with the binding of the Cl3 to the
transporter. Alternatively, the e¡ect of F3 may be
due to F3-induced cytotoxicity [13]. In this regard,
it is noteworthy that the Cl3 concentration-depen-
dent taurine uptake in insulin secreting HIT-T15 cells
decreased in a manner similar to the ‘acetate’ activity
pro¢le shown in Fig. 4 irrespective of whether Cl3
was replaced by acetate or F3 (Vinnakota, Edwards,
Sarkar, in preparation). Even though we cannot
completely rule out the possibility of F3-induced cy-
totoxicity in BAE cells based solely on our results
using the HIT-T15 cells, it is reasonable to suggest
that the e¡ect of F3 on taurine uptake is not a gen-
eral phenomenon.
3.4. Modulation of taurine uptake in BAE cells
Taurine uptake is known to be modulated by var-
ious cellular factors [6,10,14]. So we examined the
e¡ect of calcium ionophore A23187 and phorbol es-
ters on the endogenous taurine uptake in BAE cells.
As shown in Fig. 5, direct addition of A23187 (5
WM) to the uptake mixture stimulated the taurine
uptake by about 28%. Pre-treatment of BAE cells
with 100 nM of the protein kinase C activator phor-
bol ester, phorbol 12-myristate 13-acetate (PMA),
reduced the taurine uptake by V55%; however, the
inactive phorbol ester analog, 4K-phorbol 12,13-di-
decanoate (4K-PDD), was unable to mimic the e¡ect
of PMA. These results suggest, but do not necessarily
prove, that the taurine transporter in BAE cells
might be regulated by intracellular factors, such as
Ca2 and protein phosphorylation.
3.5. E¡ect of hypertonic stress on taurine uptake
Hypertonic stress modulates taurine uptake in cells
where taurine is known to play a role in cell volume
regulation [15,16]. To determine whether taurine
might play a similar role in BAE cells, we examined
the e¡ect of hypertonic stress on taurine uptake. The
uptake was stimulated signi¢cantly in BAE cells
grown in medium supplemented with either 100
mM NaCl or 200 mM ra⁄nose over cells incubated
in normal growth medium (results not shown). To
determine whether the increase is due to an e¡ect
on the Vmax or Km of taurine uptake, we measured
taurine concentration-dependent taurine uptake in
cells exposed to hyperosmotic medium or iso-osmotic
medium (Fig. 6). Analysis of the experimental results
Fig. 6. E¡ect of hypertonic stress on taurine uptake in BAE
cells. Cells were grown and exposed to iso-osmotic (control; b)
or hyperosmotic (a) condition as described in Section 2. Tau-
rine uptake was measured (30 min uptake, 37‡C) in control and
experimental cells as a function of various external [3H]taurine
concentration (1^60 WM). Smooth curve represents best ¢t of
the experimental data points to Michaelis^Menten equation.
Fig. 5. E¡ects of A23187 and phorbol esters on taurine uptake.
BAE cells were treated with A23187 and phorbol esters as de-
scribed in Section 2. Taurine uptake was measured in NaCl-1
bu¡er using 2.0 WM of [3H]taurine (60 min uptake, 37‡C). Re-
sults (average of duplicate measurements þ deviation) are ex-
pressed as percentage of uptake in untreated cells (control up-
take). *P6 0.0001.
BBAMEM 77980 5-12-00
X. Qian et al. / Biochimica et Biophysica Acta 1509 (2000) 324^334 331
shown in Fig. 6 using Michaelis^Menten equation
revealed that exposure to hyperosmotic medium in-
creased the Vmax for taurine uptake from 24.9 pmol/
mg protein per 30 min for the control cells to 51.2
pmol/mg protein per 30 min for the hypertonically
stressed experimental cells without signi¢cantly alter-
ing the Km (3.0 and 6.9 WM for the control and ex-
perimental cells, respectively) for taurine. This ob-
served increase in Vmax suggests that hypertonic
stress may have stimulated taurine uptake by increas-
ing the number of taurine transporters in BAE cells.
4. Discussion
Results described above for the ¢rst time demon-
strate clearly that the cultured BAE cells possess a
Na- and Cl3-dependent taurine transport system,
which is biochemically and pharmacologically similar
to the high-a⁄nity taurine transport system found in
a variety of mammalian tissues. Commensurate with
this conclusion, the taurine transporter encoding
cDNA isolated from the BAE cells (bTauT) showed
a high degree of sequence homology at the amino
acid level (s 92%) with the taurine transporters pre-
viously cloned from the mammalian brain, kidney,
retina, and placenta. Furthermore, the molecular
properties of the recombinantly expressed bTauT in
oocytes were also similar to those of the other cloned
mammalian taurine transporters. Collectively, these
results suggest that a high-a⁄nity taurine transporter
(bTauT) is expressed endogenously in the cultured
BAE cells.
A Na- and Cl3-dependent taurine uptake activity
was demonstrated previously in the primary cultures
of bovine brain capillary endothelial cells [3,4]. Tau-
rine uptake activity was found on both the apical and
the basolateral surface of these endothelial cells. In
both cases, the taurine uptake saturated with an ap-
parent Km of V12 WM. Our results show that the
endogenous taurine uptake in BAE cells and the
bTauT-induced taurine uptake in oocytes saturated
with a Km between 1.0 and 5.0 WM for taurine, a
value that is similar to the Km value described for
the brain capillary endothelial cells [3]. Based on
these results, we suggest that the same taurine trans-
porter is expressed in both the brain and the aortic
endothelial cells. We do not know from our results,
however, whether bTauT is the only taurine trans-
porter expressed in the BAE cells.
The physiological role of the taurine transporter in
the endothelial cells is currently not known. The
high-a⁄nity taurine transporter is most likely a key
player in transporting taurine into the endothelial
cells and also in transporting taurine across the
blood^brain barrier. The endothelial cells are ex-
posed to the shear and stress of blood £ow and to
the changes in blood osmolarity. Information regard-
ing the mechanism(s) protecting the endothelial cells
from the long-term deleterious e¡ects of shear, stress,
and osmotic changes are lacking. Thus, these cells
may possess potential mechanisms to counteract the
rise and decrease in the extracellular osmolarity, in-
cluding mechanisms involving modulation of intra-
cellular concentration of the osmolyte taurine. Our
observation that exposure to hypertonic stress re-
sulted in an increase in the Vmax of taurine uptake
in BAE cells supports the above contention. Even
though our result does not prove that taurine func-
tions as an osmolyte in the endothelial cells, a con-
comitant increase in intracellular taurine in response
to hypertonicity is a prerequisite if taurine were to
play the role of an osmolyte in endothelial cells. Re-
cent demonstration that hypo-osmotic swelling acti-
vated taurine e¥ux in cultured calf pulmonary endo-
thelial cells [17] also adds support to the idea that
taurine might act as an osmolyte in endothelial cells.
Taurine was also suggested to play a cytoprotec-
tive role in human umbilical endothelial cells [18] and
in human vascular endothelial cells [19] because of its
ability to prevent stimuli-induced and high glucose-
induced apoptosis, respectively. Although the exact
mechanism by which taurine prevented cell damage
in these studies remains to be elucidated, a critical
factor required for the cytoprotective action of tau-
rine may involve mechanisms that maintain the intra-
cellular taurine content. Treatment with glucose may
decrease the intracellular taurine content of the en-
dothelial cells, possibly by downregulating the tau-
rine transporter [20], and may consequently contrib-
ute to the endothelial cell apoptosis. Consistent with
this idea, we have observed V40% decrease in tau-
rine uptake level in glucose-treated BAE cells (65 mM
glucose for 3 days) compared to that in the untreated
(control) BAE cells (Sarkar, unpublished observa-
tion). Pre-incubation with taurine would raise the
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intracellular taurine content, which may explain why
taurine prevented glucose-mediated apoptosis in en-
dothelial cells [19]. Our observation that glucose
treatment reduced relative taurine uptake level in
BAE cells suggests that chronic exposure to high
glucose concentrations may lead to a decrease in
the intracellular taurine content, which may be a
causal factor for the hyperglycemia-triggered vascu-
lar lesions found in human and experimental ani-
mals.
In summary, our studies provide the ¢rst molecu-
lar evidence that endothelial cells express a high-af-
¢nity taurine transporter, via which these cells can
actively accumulate taurine from the extracellular
medium (i.e., circulating plasma). It is noteworthy
that taurine was shown to attenuate the e¡ects of
several cytotoxic agents in a variety of tissues and
cells, where taurine transporter is also expressed
[1,21]. Thus, we propose that the maintenance of
the intracellular taurine content via the high-a⁄nity
taurine transporter is one of the mechanisms by
which the endothelial cells counteract the deleterious
e¡ects of osmotic stress and a number of other cyto-
toxic agents.
Acknowledgements
The authors thank Daniel Medrano and Fredelian
Pieri for microinjection of oocytes. H.K.S. also
thanks AHA for grant support (Grant-in-Aid No.
95012109).
References
[1] R.J. Huxtable, Physiological actions of taurine, Physiol.
Rev. 72 (1992) 101^163.
[2] I. Tayarani, I. Cloez, J.M. Lefauconnier, J.M. Bourre, So-
dium-dependent high-a⁄nity uptake of taurine by isolated
rat brain capillaries, Biochim. Biophys. Acta 985 (1989) 168^
172.
[3] I. Tamai, M. Senmaru, T. Terasaki, A. Tsuji, Na(+)- and
Cl(3)-dependent transport of taurine at the blood^brain
barrier, Biochem. Pharmacol. 50 (1995) 1783^1793.
[4] A. Tsuji, I. Tamai, Sodium- and chloride-dependent trans-
port of taurine at the blood^brain barrier, Adv. Exp. Med.
Biol. 403 (1996) 385^391.
[5] H. Benrabh, J.M. Bourre, J.M. Lefauconnier, Taurine trans-
port at the blood^brain barrier: an in vivo brain perfusion
study, Brain Res. 692 (1995) 57^65.
[6] S. Vinnakota, X. Qian, H. Egal, V. Sarthy, H.K. Sarkar,
Molecular characterization and in situ localization of a
mouse retinal taurine transporter, J. Neurochem. 69 (1997)
2238^2250.
[7] W. Dai, S. Vinnakota, X. Qian, D.L. Kunze, H.K. Sarkar,
Molecular characterization of the human CRT-1 creatine
transporter expressed in Xenopus oocytes, Arch. Biochem.
Biophys. 251 (1999) 75^84.
[8] M. Ruiz, H. Egal, V. Sarthy, X. Quin, H.K. Sarkar, Clon-
ing, expression, and localization of a mouse retinal gamma-
aminobutyric acid transporter, Invest. Ophthalmol. Vis. Sci.
36 (1994) 4039^4048.
[9] C.J. Markus-Sekura, M.J. Hitchcock, Preparation of oocytes
for microinjection of RNA and DNA, Methods Enzymol.
152 (1987) 284^288.
[10] S. Ramamoorthy, F.H. Leibach, V.B. Mahesh, Y. Ham, T.
Yang-Feng, R.D. Blakely, V. Ganapathy, Functional char-
acterization and chromosomal localization of a cloned tau-
rine transporter from human placenta, Biochem. J. 30 (1994)
893^900.
[11] K.E. Smith, L.A. Borden, C.-H. Wang, P.R. Hartig, T.A.
Branchek, R.L. Weinshank, Cloning and expression of a
high a⁄nity taurine transporter from rat brain, Mol. Phar-
macol. 42 (1992) 563^569.
[12] S. Uchida, H.M. Kwon, A. Yamaguchi, A.S. Preston, F.
Marumo, J.S. Handler, Molecular cloning of the cDNA
for an MDCK cell Na(+)- and Cl(3)-dependent taurine
transporter that is regulated by hypertonicity, Proc. Natl.
Acad. Sci. USA 89 (1992) 8230^8234.
[13] T. Tsutsui, N. Suzuki, M. Ohmori, H. Maizumi, Cytotoxic-
ity, chromosome aberrations and unscheduled DNA synthe-
sis in cultured human diploid ¢broblasts induced by sodium
£uoride, Mutat. Res. 139 (1984) 193^198.
[14] D.D.F. Loo, J.R. Hirsch, H.K. Sarkar, E.M. Wright, Reg-
ulation of the mouse retinal taurine transporter (TAUT) by
protein kinases in Xenopus oocytes, FEBS Lett. 392 (1996)
250^254.
[15] M.B. Burg, E.D. Kwon, D. Kultz, Regulation of gene ex-
pression by hypertonicity, Annu. Rev. Physiol. 59 (1997)
437^455.
[16] H. Pasantes-Morales, O. Quesada, J. Moran, Taurine: an
osmolyte in mammalian tissues, Adv. Exp. Med. Biol. 442
(1998) 209^217.
[17] V.G. Manolopoulos, T. Voets, P.E. Ceclercq, G. Droog-
mans, B. Nilius, Swelling-activated e¥ux of taurine and oth-
er organic osmolyte in endothelial cells, Am. J. Physiol. 273
(1997) C214^C222.
[18] J.H. Wang, H.P. Redmond, R.W. Watson, C. Condron, D.
Bouchier-Hayes, The bene¢cial e¡ect of taurine on the pre-
vention of human endothelial cell death, Shock 6 (1996) 331^
338.
BBAMEM 77980 5-12-00
X. Qian et al. / Biochimica et Biophysica Acta 1509 (2000) 324^334 333
[19] Q.D. Wu, J.H. Wang, F. Fennessy, H.P. Redmond, D.
Bouchier-Hayes, Taurine prevents high-glucose-induced hu-
man vascular endothelial cell apoptosis, Am. J. Physiol. 277
(1999) C1229^C1238.
[20] M.J. Stevens, Y. Hosaka, J.A. Masterson, S.M. Jones, T.P.
Thomas, D.D. Larkin, Downregulation of human taurine
transporter by glucose in cultured retinal pigment epithelial
cells, Am. J. Physiol. 277 (1999) E760^E771.
[21] J.A. Timbrell, V. Seabra, C.J. Water¢eld, The in vivo and in
vitro protective properties of taurine, Gen. Pharmacol. 26
(1995) 453^462.
BBAMEM 77980 5-12-00
X. Qian et al. / Biochimica et Biophysica Acta 1509 (2000) 324^334334
